These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10717080)

  • 1. New Directions in Radionuclide Sources for Brachytherapy.
    Nath R
    Semin Radiat Oncol; 1993 Oct; 3(4):278-289. PubMed ID: 10717080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP; Lin CC; Leeper DB; Waterman FM
    Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
    J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a rat solid tumor model for continuous low-dose-rate irradiation studies using 125I and 103Pd sources.
    Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
    Brachytherapy; 2004; 3(3):159-72. PubMed ID: 15533809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer gel dosimetry close to an 125I interstitial brachytherapy seed.
    Pantelis E; Lymperopoulou G; Papagiannis P; Sakelliou L; Stiliaris E; Sandilos P; Seimenis I; Kozicki M; Rosiak JM
    Phys Med Biol; 2005 Sep; 50(18):4371-84. PubMed ID: 16148399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of off-centering on dose uniformity along and around blood vessels undergoing catheter-based intravascular brachytherapy.
    Nath R; Yue N
    Cardiovasc Radiat Med; 2004; 5(2):88-96. PubMed ID: 15464946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation exposure after permanent prostate brachytherapy.
    Cattani F; Vavassori A; Polo A; Rondi E; Cambria R; Orecchia R; Tosi G
    Radiother Oncol; 2006 Apr; 79(1):65-9. PubMed ID: 16564593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brachytherapy for Head and Neck Cancer.
    Goffinet DR
    Semin Radiat Oncol; 1993 Oct; 3(4):250-259. PubMed ID: 10717077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
    Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
    Int J Radiat Biol; 2005 Sep; 81(9):689-99. PubMed ID: 16368647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brachytherapy for prostate cancer: high dose rate or low-dose rate?].
    Cosset JM; Haie-Meder C
    Cancer Radiother; 2005 Dec; 9(8):610-9. PubMed ID: 16226473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric penumbra effects in catheter-based intravascular brachytherapy using a centered photon or beta line source.
    Yue N; Nath R; Roberts K
    Cardiovasc Radiat Med; 2000; 2(1):32-8. PubMed ID: 11229060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (144)Ce as a potential candidate for interstitial and intravascular brachytherapy.
    Zilio VO; Joneja OP; Popowski Y; Bochud FO; Chawla R
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):585-94. PubMed ID: 15890604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologically effective dose (BED) for interstitial seed implants containing a mixture of radionuclides with different half-lives.
    Chen Z; Nath R
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):825-34. PubMed ID: 12573770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-beam transmission data for new brachytherapy sources, Tm-170 and Yb-169.
    Granero D; Pérez-Calatayud J; Ballester F; Bos AJ; Venselaar J
    Radiat Prot Dosimetry; 2006; 118(1):11-5. PubMed ID: 16030058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 60cobalt and 192iridium sources in high dose rate afterloading brachytherapy.
    Richter J; Baier K; Flentje M
    Strahlenther Onkol; 2008 Apr; 184(4):187-92. PubMed ID: 18398582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung.
    Trombetta MG; Colonias A; Makishi D; Keenan R; Werts ED; Landreneau R; Parda DS
    Brachytherapy; 2008; 7(1):50-4. PubMed ID: 18299113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric penumbra effects in catheter-based intravascular brachytherapy using a centered photon or beta line source.
    Yue N; Nath R; Roberts K
    Cardiovasc Radiat Med; 2001 Jan; 2(1):32-38. PubMed ID: 11068253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of high-dose rate brachytherapy in locally advanced prostate cancer.
    Vicini FA; Vargas C; Edmundson G; Kestin L; Martinez A
    Semin Radiat Oncol; 2003 Apr; 13(2):98-108. PubMed ID: 12728439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Principles of curietherapy].
    Housset M
    Rev Prat; 1994 Apr; 44(8):1040-3. PubMed ID: 7939321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.